167 related articles for article (PubMed ID: 10493304)
1. Oral contraceptives and ovarian cancer.
La Vecchia C; Franceschi S
Eur J Cancer Prev; 1999 Aug; 8(4):297-304. PubMed ID: 10493304
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptives and ovarian cancer: an update, 1998-2004.
La Vecchia C
Eur J Cancer Prev; 2006 Apr; 15(2):117-24. PubMed ID: 16523008
[TBL] [Abstract][Full Text] [Related]
3. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
Petitti DB; Porterfield D
Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.
; Beral V; Doll R; Hermon C; Peto R; Reeves G
Lancet; 2008 Jan; 371(9609):303-14. PubMed ID: 18294997
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptives and neoplasia of the ovary.
Stanford JL
Contraception; 1991 Jun; 43(6):543-56. PubMed ID: 1868732
[TBL] [Abstract][Full Text] [Related]
6. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer.
Rosenberg L; Palmer JR; Zauber AG; Warshauer ME; Lewis JL; Strom BL; Harlap S; Shapiro S
Am J Epidemiol; 1994 Apr; 139(7):654-61. PubMed ID: 8166126
[TBL] [Abstract][Full Text] [Related]
7. The effects of oral contraceptives and parity on ovarian cancer trends in women under 55 years of age.
Villard-Mackintosh L; Vessey MP; Jones L
Br J Obstet Gynaecol; 1989 Jul; 96(7):783-8. PubMed ID: 2788456
[TBL] [Abstract][Full Text] [Related]
8. Ovarian neoplasms, functional ovarian cysts, and oral contraceptives.
Vessey M; Metcalfe A; Wells C; McPherson K; Westhoff C; Yeates D
Br Med J (Clin Res Ed); 1987 Jun; 294(6586):1518-20. PubMed ID: 3111618
[TBL] [Abstract][Full Text] [Related]
9. Epithelial ovarian cancer and combination oral contraceptives.
Rosenberg L; Shapiro S; Slone D; Kaufman DW; Helmrich SP; Miettinen OS; Stolley PD; Rosenshein NB; Schottenfeld D; Engle RL
JAMA; 1982 Jun; 247(23):3210-2. PubMed ID: 7045417
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptives and gynecologic cancer: an update for the 1990s.
Kaunitz AM
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1171-6. PubMed ID: 1415442
[TBL] [Abstract][Full Text] [Related]
11. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.
dos Santos Silva I; Swerdlow AJ
Br J Cancer; 1995 Aug; 72(2):485-92. PubMed ID: 7640237
[TBL] [Abstract][Full Text] [Related]
12. The reduction in risk of ovarian cancer associated with oral-contraceptive use.
Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development
N Engl J Med; 1987 Mar; 316(11):650-5. PubMed ID: 3821795
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptives and life expectancy.
Fortney JA; Harper JM; Potts M
Stud Fam Plann; 1986; 17(3):117-25. PubMed ID: 3523849
[TBL] [Abstract][Full Text] [Related]
14. Combined oral contraceptives: risks and benefits.
Thorogood M; Villard-Mackintosh L
Br Med Bull; 1993 Jan; 49(1):124-39. PubMed ID: 8324603
[TBL] [Abstract][Full Text] [Related]
15. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
[TBL] [Abstract][Full Text] [Related]
16. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use.
Franceschi S; Parazzini F; Negri E; Booth M; La Vecchia C; Beral V; Tzonou A; Trichopoulos D
Int J Cancer; 1991 Aug; 49(1):61-5. PubMed ID: 1874572
[TBL] [Abstract][Full Text] [Related]
17. [The risk of breast cervical, endometrial and ovarian cancer in oral contraceptive users].
Veljković M; Veljković S
Med Pregl; 2010; 63(9-10):657-61. PubMed ID: 21446095
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer.
Faber MT; Jensen A; Frederiksen K; Glud E; Høgdall E; Høgdall C; Blaakaer J; Kjaer SK
Cancer Causes Control; 2013 Dec; 24(12):2197-206. PubMed ID: 24077761
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for epithelial ovarian tumours of borderline malignancy.
Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
[TBL] [Abstract][Full Text] [Related]
20. Noncontraceptive health benefits of oral steroidal contraceptives.
Mishell DR
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):809-16. PubMed ID: 7065059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
